In hepatocellular carcinoma, almost 80% of tumor samples exhibited GPx3 hypermethylation, leading to its markedly reduced mRNA and protein levels, suggesting its potential as a broad-spectrum tumor screening marker due to its measurable presence in plasma [61]. Here, GPX3 is linked to hepatocellular carcinoma.